Skip to main content
SpringerLink
Log in

Ductal Carcinoma In Situ

  • Living reference work entry
  • First Online:
Book cover Encyclopedia of Pathology

Part of the book series: Encyclopedia of Pathology ((EP))

  • 115 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References and Further Reading

  • Abba, M. C., Drake, J. A., Hawkins, K. A., et al. (2004). Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression. Breast Cancer Research, 6, R499–R513.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Abba, M. C., Gong, T., Lu, Y., et al. (2015). A molecular portrait of high-grade ductal carcinoma in situ. Cancer Research, 75, 3980–3990.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Adriance, M. C., Inman, J. L., Petersen, O. W., et al. (2005). Myoepithelial cells: Good fences make good neighbors. Breast Cancer Research, 7, 190–197.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Allinen, M., Beroukhim, R., Cai, L., et al. (2004). Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell, 6, 17–32.

    Article  CAS  PubMed  Google Scholar 

  • Anderson, W. F., & Devesa, S. S. (2005). In situ male breast carcinoma in the surveillance, epidemiology, and end results database of the National Cancer Institute. Cancer, 104, 1733–1741.

    Article  PubMed  Google Scholar 

  • Aubele, M., Cummings, M., Walsch, A., et al. (2000). Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma. Analytical Cellular Pathology, 20, 17–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bellamy, C. O., McDonald, C., Salter, D. M., et al. (1993). Noninvasive ductal carcinoma of the breast: The relevance of histologic categorization. Human Pathology, 24, 16–23.

    Article  CAS  PubMed  Google Scholar 

  • Böcker, W. (2006). Preneoplasia of the breast. A new conceptual approach to proliferative breast disease. Munich: Elsevier GmbH.

    Google Scholar 

  • Bombonati, A., & Sgroi, D. C. (2011). The molecular pathology of breast cancer progression. Journal of Pathology, 223, 307–317.

    Article  CAS  PubMed  Google Scholar 

  • Bratthauer, G. L., Moinfar, F., Stamatakos, M. D., et al. (2002). Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Human Pathology, 33, 620–627.

    Article  CAS  PubMed  Google Scholar 

  • Casasent, A. K., Edgerton, M., & Navin, N. E. (2017). Genome evolution in ductal carcinoma in situ: Invasion of the clones. Journal of Pathology, 241, 208–218.

    Article  PubMed  Google Scholar 

  • Castellano, I., Marchiò, C., Tomatis, M., et al. (2010). Micropapillary ductal carcinoma in situ of the breast: An inter-institutional study. Modern Pathology, 23, 260–269.

    Article  CAS  PubMed  Google Scholar 

  • Comparison of Operative to Monitoring and Endocrine Therapy (COMET). Trial For Low Risk DCIS (COMET). https://clinicaltrials.gov/ct2/show/NCT02926911

  • Curigliano, G., Disalvatore, D., Esposito, A., et al. (2015). Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ. Annals of Oncology, 26, 682–687.

    Article  CAS  PubMed  Google Scholar 

  • Decensi, A., Puntoni, M., Pruneri, G., et al. (2011). Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial. Cancer Prevention Research, 4, 1181–1189.

    Article  CAS  PubMed  Google Scholar 

  • Elsayegh, N., Kuerer, H. M., Lin, H., et al. (2014). Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing. Annals of Oncology, 21, 3466–3472.

    Article  Google Scholar 

  • Elshof, L. E., Tryfonidis, K., Slaets, L., et al. (2015). Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – the LORD study. European Journal of Cancer, 51, 1497–1510.

    Article  PubMed  Google Scholar 

  • EORTC Breast Cancer Cooperative Group, EORTC Radiotherapy Group, Bijker, N., et al. (2006). Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 – a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Journal of Clinical Oncology, 24, 3381–3387.

    Article  Google Scholar 

  • Erbas, B., Provenzano, E., Armes, J., et al. (2006). The natural history of ductal carcinoma in situ of the breast: A review. Breast Cancer Research and Treatment, 97, 135–144.

    Article  PubMed  Google Scholar 

  • Ernster, V. L., & Barclay, J. (1997). Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: A dilemma. Journal of the National Cancer Institute Monographs, 22, 151–156.

    Article  Google Scholar 

  • Ernster, V. L., Barclay, J., Kerlikowske, K., et al. (2000). Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Archives of Internal Medicine, 160, 953–958.

    Article  CAS  PubMed  Google Scholar 

  • Ernster, V. L., Ballard-Barbash, R., Barlow, W. E., et al. (2002). Detection of ductal carcinoma in situ in women undergoing screening mammography. Journal of the National Cancer Institute, 94, 1546–1554.

    Article  PubMed  Google Scholar 

  • Francis, A., Fallowfield, L., & Rea, D. (2015). The LORIS trial: Addressing overtreatment of ductal carcinoma in situ. Clinical Oncology, 27, 6–8.

    Article  CAS  PubMed  Google Scholar 

  • Galimberti, V., Monti, S., & Mastropasqua, M. G. (2013). DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN). Breast, 22, 431–435.

    Article  PubMed  Google Scholar 

  • Giuseppetti, G. M., Boria, F., & Baldassare, S. (2018). DCIS imaging. In C. Mariotti (Ed.), Ductal carcinoma in situ (pp. 39–57). Cham: Springer.

    Chapter  Google Scholar 

  • Greenwood, H. I., Heller, S. L., Kim, S., et al. (2013). Ductal carcinoma in situ of the breasts: Review of MR imaging features. Radiographics, 33, 1569–1588.

    Article  PubMed  Google Scholar 

  • Hannafon, B. N., Sebastiani, P., de las Morenas, A., et al. (2011). Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Research, 13, R24.

    Article  CAS  PubMed  Google Scholar 

  • Holmes, P., Lloyd, J., Chervoneva, I., et al. (2011). Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone. Cancer, 117, 3650–3657.

    Article  CAS  PubMed  Google Scholar 

  • Kim, S. Y., Jung, S. H., Kim, M. S., et al. (2015). Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer. Oncotarget, 6, 7597–7607.

    PubMed  PubMed Central  Google Scholar 

  • King, M. T., Winters, Z. E., Olivotto, I. A., et al. (2017). Patient-reported outcomes in ductal carcinoma in situ: A systematic review. European Journal of Cancer, 71, 95–108.

    Article  PubMed  Google Scholar 

  • Kong, I., Narod, S. A., Taylor, C., et al. (2014). Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: A population-based outcomes analysis. Current Oncology, 21, e96–e104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kuerer, H. M., Buzdar, A. U., Mittendorf, E. A., et al. (2011). Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast. Cancer, 117, 39–47.

    Article  CAS  PubMed  Google Scholar 

  • Lakhani, S. R., Ellis, I. O., Schnitt, S. J., et al. (2012). WHO classification of tumors of the breast. Lyon: International Agency for Research on Cancer.

    Google Scholar 

  • Lopez-Garcia, M. A., Geyer, F. C., Lacroix-Triki, M., et al. (2010). Breast cancer precursors revisited: Molecular features and progression pathways. Histopathology, 57, 171–192.

    Article  PubMed  Google Scholar 

  • Lyman, G. H., Temin, S., Edge, S. B., et al. (2014). Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology, 32, 1365–1383.

    Article  PubMed  Google Scholar 

  • Mardekian, S. K., Bombonati, A., & Palazzo, J. P. (2016). Ductal carcinoma in situ of the breast: The importance of morphologic and molecular interactions. Human Pathology, 49, 114–123.

    Article  CAS  PubMed  Google Scholar 

  • Margolese, R. G., Cecchini, R. S., Julian, T. B., et al. (2016). Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): A randomised, double-blind, phase 3 clinical trial. Lancet, 387, 849–856.

    Article  CAS  PubMed  Google Scholar 

  • McCormick, B., Winter, K., Hudis, C., et al. (2015). RTOG 9804: A prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. Journal of Clinical Oncology, 33, 709–715.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mustonen, M., Raunio, H., Pääkkö, P., et al. (1997). The extent of apoptosis is inversely associated with bcl-2 expression in premalignant and malignant breast lesions. Histopathology, 31, 347–354.

    Article  CAS  PubMed  Google Scholar 

  • NCCN. (2015). Guidelines: https://www.nccn.org/professionals/physician_gls/default.aspx

  • Page, D. L., & Rogers, L. W. (1992). Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Human Pathology, 23, 1095–1097.

    Article  CAS  PubMed  Google Scholar 

  • Patchefsky, A. S., Schwartz, G. F., Finkelstein, S. D., et al. (1989). Heterogeneity of intraductal carcinoma of the breast. Cancer, 63, 731–741.

    Article  CAS  PubMed  Google Scholar 

  • Pilewskie, M., & Morrow, M. (2018). Margins in breast cancer: How much is enough? Cancer, 124, 1335–1341.

    Article  PubMed  Google Scholar 

  • Pluchinotta, A. (2018). History of the DCIS of the breast and the evolution of knowledge based on ductal tree anatomy. In C. Mariotti (Ed.), Ductal Carcinoma in situ (pp. 1–23). Cham: Springer.

    Google Scholar 

  • Polyak, K., & Hu, M. (2005). Do myoepithelial cells hold the key for breast tumor progression? Journal of Mammary Gland Biology and Neoplasia, 10, 231–247.

    Article  PubMed  Google Scholar 

  • Rakha, E. A., Miligy, I. M., Gorringe, K. L., et al. (2017). Invasion in breast lesions: The role of the epithelial-stroma barrier. Histopathology, 72, 1075. https://doi.org/10.1111/his.13446.

    Article  Google Scholar 

  • Ravaioli, S., Tumedei, M. M., Foca, F., et al. (2017). Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy. International Journal of Experimental Pathology, 98, 289–295.

    Article  CAS  PubMed  Google Scholar 

  • Reis-Filho, J. S., & Lakhani, S. R. (2003). The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesions. Breast Cancer Research, 5, 313–319.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reis-Filho, J. S., Simpson, P. T., Gale, T., et al. (2005). The molecular genetics of breast cancer: The contribution of comparative genomic hybridization. Pathology, Research and Practice, 201, 713–725.

    Article  PubMed  Google Scholar 

  • Rominger, M., Berg, D., Frauenfelder, T., et al. (2016). Which factors influence MRI-pathology concordance of tumour size measurements in breast cancer? European Radiology, 26, 1457–1465.

    Article  CAS  PubMed  Google Scholar 

  • Rutter, C. E., Park, H. S., Killelea, B. K., et al. (2015). Growing use of mastectomy for ductal carcinoma-in situ of the breast among young women in the United States. Annals of Surgical Oncology, 22, 2378–2386.

    Article  PubMed  Google Scholar 

  • Shackney, S. E., & Silverman, J. F. (2003). Molecular evolutionary patterns in breast cancer. Advances in Anatomic Pathology, 10, 278–290.

    Article  CAS  PubMed  Google Scholar 

  • Siziopikou, K. P., Anderson, S. J., Cobleigh, M. A., et al. (2013). Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43. Breast Cancer Research and Treatment, 142, 415–421.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Solin, L. J., Gray, R., Baehner, F. L., et al. (2013). A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. Journal of the National Cancer Institute, 105, 701–710.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Staerkle, R. F., Lenzlinger, P. M., Suter, S. L., et al. (2006). Synchronous bilateral ductal carcinoma in situ of the male breast associated with gynecomastia in a 30-year-old patient following repeated injections of stanozolol. Breast Cancer Research and Treatment, 97, 173–176.

    Article  PubMed  Google Scholar 

  • Surveillance, Epidemiology, and End Results (SEER) Program. (2014). National Cancer Institute. https://seer.cancer.gov/csr/1975_2014/

  • Tavassoli, F. A., & Devilee, P. (2003). World Health Organization classification of tumors of the breast. Lyon: International Agency for Research on Cancer.

    Google Scholar 

  • Tot, T., & Gere, M. (2008). Radiological-pathological correlation in diagnosing breast carcinoma: The role of pathology in the multimodality era. Pathology & Oncology Research, 14, 173–178.

    Article  Google Scholar 

  • Verkooijen, H. M., Fioretta, G., De Wolf, C., et al. (2002). Management of women with ductal carcinoma in situ of the breast: A population-based study. Annals of Oncology, 13, 1236–1245.

    Article  CAS  PubMed  Google Scholar 

  • Vincent-Salomon, A., Lucchesi, C., Gruel, N., et al. (2008). Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast. Clinical Cancer Research, 14, 1956–1965.

    Article  CAS  PubMed  Google Scholar 

  • Volinia, S., Galasso, M., Sana, M. E., et al. (2012). Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proceedings of the National Academy of Sciences of the United States of America, 109, 3024–3029.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wai, E. S., Lesperance, M. L., Alexander, C. S., et al. (2011). Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone. Annals of Surgical Oncology, 18, 119–124.

    Article  PubMed  Google Scholar 

  • Wapnir, I. L., Dignam, J. J., Fisher, B., et al. (2011). Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. Journal of the National Cancer Institute, 103, 478–488.

    Article  PubMed  PubMed Central  Google Scholar 

  • Yates, L. R., Gerstung, M., Knappskog, S., et al. (2015). Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nature Medicine, 21, 751–759.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Sciences, University of Turin, Turin, Italy

    Isabella Castellano

  2. Department of Oncology, University of Turin, Turin, Italy

    Jasna Metovic

Authors
  1. Isabella Castellano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jasna Metovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Isabella Castellano .

Editor information

Editors and Affiliations

  1. NIJMEGEN, The Netherlands

    J.H.J.M. van Krieken

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Castellano, I., Metovic, J. (2018). Ductal Carcinoma In Situ. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_4706-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28845-1_4706-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28845-1

  • Online ISBN: 978-3-319-28845-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation